JBIO - Aerovate Therapeutics, Inc.


25.21
-0.170   -0.674%

Share volume: 683,877
Last Updated: 04-23-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.16%

PREVIOUS CLOSE
CHG
CHG%

$25.38
-0.17
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q3 2025 Q4 2025
Report Date 05-13-2024 08-12-2024 11-12-2024 03-27-2025 04-25-2025 11-14-2025 03-06-2026
Cash flow financing 471.000 K 24.380 M 22.000 K 554.000 K 0.000 0.000 170.160 M
Other financing cash flows 704.000 K 511.000 K 22.000 K 247.000 K 0.000 -156.000 K 244.000 K
Cash flow -14.369 M 21.947 M 46.000 K 2.636 M 10.469 M 0.000 38.349 M
Net income -23.186 M -24.775 M -16.237 M -5.430 M -2.518 M -25.175 M -67.583 M
Depreciation 28.000 K 28.000 K 218.000 K 8.000 K 4.000 K 12.000 K 9.000 K
Changes in inventories 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Changes in receivables 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Cashflow 8.833 M 18.000 M 16.067 M 13.129 M 12.850 M -148.708 M -98.162 M
Net Borrowings 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Activity Other 0.000 0.000 0.000 0.000 0.000 0.000 28.000 K
Dividends Paid 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Exchange Rate Effect 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Capital Expenditures 0.000 0.000 0.000 0.000 0.000 57.000 K 3.000 K
Cash Change -14.369 M 21.947 M 46.000 K 2.636 M 10.469 M -170.836 M 38.332 M